Skip to main content

Table 4 Representative scores (most frequently observed) of the immunolabeling, categorized as mild/discrete (+), moderate (++), or intense (+++), according to the area/quantity of positive cells for each antigen in all groups in both periods

From: Gene expression, immunohistochemical and microarchitectural evaluation of bone formation around two implant surfaces placed in bone defects filled or not with bone substitute material

  RUNX2 OPN OCN OPG RANKL
15 days
 BC-N +++ ++ +++ ++ +++
 HA/TCP-N +++ +++ +++ +++ +++
 BC-A +++ ++ ++ ++ ++
 HA/TCP-A ++ ++ ++ ++ ++
30 days
 BC-N + ++ ++ ++ ++
 HA/TCP-N ++ + ++ ++ ++
 BC-A +++ ++ ++ ++ ++
 HA/TCP-A ++ ++ ++ ++ ++